Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility.

Données et ressources

Info additionnelle

Champ Valeur
Source
Version
Producteur
Courriel de l'auteur
Mainteneur
Courriel du mainteneur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis – Publication de l'ICH S5(R3): Détection de la toxicité sur la reproduction et sur la fertilité des mâles des produits pharmaceutiques destinés aux humains
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Langue
Contact Person
Contact Email
Dictionnaire de données
Open Canada Date Published 2020-08-10 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["avis", "Conseil international pour l'harmonisation", "exigences techniques ICH", "orientation S5(R3)", "détection de la toxicité", "reproduction pour les médicaments", "toxicité pour la fertilité masculine"], "en": ["notice", "International Council for-Harmonisation", "ICH Technical Requirements", "guidance S5(R3)", "detection of toxicity", "reproduction for medicinal-products", "toxicity to male-fertility"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source